Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, December 7, 2015
[ Mon, Dec 07th 2015
] - WOPRAI
[ Mon, Dec 07th 2015
] - WOPRAI
[ Mon, Dec 07th 2015
] - WOPRAI
[ Mon, Dec 07th 2015
] - WOPRAI
[ Mon, Dec 07th 2015
] - WOPRAI
[ Mon, Dec 07th 2015
] - WOPRAI
Fri, December 4, 2015
[ Fri, Dec 04th 2015
] - WOPRAI
[ Fri, Dec 04th 2015
] - WOPRAI
[ Fri, Dec 04th 2015
] - WOPRAI
[ Fri, Dec 04th 2015
] - WOPRAI
[ Fri, Dec 04th 2015
] - WOPRAI
Thu, December 3, 2015
[ Thu, Dec 03rd 2015
] - WOPRAI
Wed, December 2, 2015
[ Wed, Dec 02nd 2015
] - WOPRAI
[ Wed, Dec 02nd 2015
] - WOPRAI
[ Wed, Dec 02nd 2015
] - WOPRAI
[ Wed, Dec 02nd 2015
] - WOPRAI
[ Wed, Dec 02nd 2015
] - WOPRAI
Tue, December 1, 2015
[ Tue, Dec 01st 2015
] - WOPRAI
[ Tue, Dec 01st 2015
] - WOPRAI
[ Tue, Dec 01st 2015
] - WOPRAI
[ Tue, Dec 01st 2015
] - WOPRAI
[ Tue, Dec 01st 2015
] - WOPRAI
Paul Matteis Initiated (VRTX) at Strong Buy and Held Target at $125 on, Dec 1st, 2015
Paul Matteis of Stifel, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy and Held Target at $125 on, Dec 1st, 2015.
Paul has made no other calls on VRTX in the last 4 months.
There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Biren Amin of "Jefferies" Initiated at Hold and Held Target at $130 on, Wednesday, September 9th, 2015
These are the ratings of the 3 analyists that currently disagree with Paul
- Andrew Fein of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $155 on, Friday, October 30th, 2015
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $148 on, Friday, October 2nd, 2015
- Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, September 28th, 2015
